Additionally, in PTC patients, we found that the percentages of CD45+ lymphocytes and HLA-DR+CD14+ monocytes were higher in tumor tissue compared to non-tumoral tissue and peripheral blood. This evidence concerns the gene CD14 and neoplasm.